Continuum Advisory LLC Makes New Investment in Cigna Group $CI

Continuum Advisory LLC acquired a new position in shares of Cigna Group (NYSE:CI) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 18,483 shares of the health services provider’s stock, valued at approximately $5,087,000.

Several other institutional investors also recently bought and sold shares of the company. Daiwa Securities Group Inc. increased its holdings in Cigna Group by 4.4% during the 4th quarter. Daiwa Securities Group Inc. now owns 94,875 shares of the health services provider’s stock worth $26,112,000 after purchasing an additional 4,038 shares during the period. State of Wyoming increased its holdings in shares of Cigna Group by 1,383.3% in the 4th quarter. State of Wyoming now owns 2,759 shares of the health services provider’s stock valued at $759,000 after acquiring an additional 2,573 shares during the period. Cibc World Market Inc. increased its holdings in shares of Cigna Group by 58.7% in the 4th quarter. Cibc World Market Inc. now owns 38,320 shares of the health services provider’s stock valued at $10,547,000 after acquiring an additional 14,169 shares during the period. Sivia Capital Partners LLC increased its holdings in shares of Cigna Group by 152.0% in the 4th quarter. Sivia Capital Partners LLC now owns 1,988 shares of the health services provider’s stock valued at $547,000 after acquiring an additional 1,199 shares during the period. Finally, Private Wealth Asset Management LLC increased its holdings in shares of Cigna Group by 41.5% in the 4th quarter. Private Wealth Asset Management LLC now owns 266 shares of the health services provider’s stock valued at $73,000 after acquiring an additional 78 shares during the period. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Trading Up 3.7%

Shares of NYSE:CI opened at $280.86 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market capitalization of $74.30 billion, a P/E ratio of 11.91, a P/E/G ratio of 1.04 and a beta of 0.28. The business’s 50-day moving average is $279.18 and its 200 day moving average is $277.15. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter last year, the company earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts predict that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Leerink Partners lifted their price target on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday, February 6th. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. The Goldman Sachs Group lifted their price target on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and cut their price target for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Finally, Jefferies Financial Group cut their price target on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and an average target price of $338.30.

Insiders Place Their Bets

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.